Stock Movers Johnson & Johnson Drops, Kraft Heinz Declines, Nathan's Famous Surges
Jan 21, 2026
Johnson & Johnson faces a 3.1% drop after reporting mixed drug sales and a court loss over baby powder, despite optimistic guidance for 2026. Meanwhile, Kraft Heinz declines as Berkshire Hathaway prepares to sell a significant portion of its shares. In a surprising twist, Nathan's Famous sees a surge in its stock price after being acquired by Smithfield Foods for $450 million, raising intriguing questions about brand continuity and its cultural significance.
AI Snips
Chapters
Transcript
Episode notes
J&J Hit By Litigation Despite Solid Guidance
- Johnson & Johnson shares fell after losing a major baby powder court battle despite stronger-than-expected earnings and 2026 guidance.
- The company plans to appeal while investors worry litigation risks could outweigh drug-sales growth.
Cancer Drugs Are Driving J&J's Outlook
- J&J's 2026 sales guidance beat analyst estimates and is expected to be driven by cancer drug sales.
- This suggests political pressure to cut drug prices may not severely harm pharma earnings as feared.
Berkshire's Exit Underscores Kraft Heinz Struggles
- Kraft Heinz shares fell after reports Berkshire Hathaway may sell its nearly 30% stake.
- The move highlights investor skepticism about Kraft Heinz's turnaround and its 70% share decline since 2017.